Atlas Trials

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

Clinical trial NCT07345689 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07345689
Sponsor
Xuanzhu Biopharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatic InsufficiencyRenal InsufficiencyElderly
Start date
2026-01-30
Primary completion
2026-10-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.